60 DEGREES PHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Fair Value
60 DEGREES PHARMACEUTICALS, INC. (SXTP) reported Adjustments to Additional Paid in Capital, Fair Value of $57.05 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket · last filed 2023-11-20
- 60 DEGREES PHARMACEUTICALS, INC. adjustments to additional paid in capital, fair value for the quarter ending 2023-09-30 was $57.05K, a 153.62% increase year-over-year.
- 60 DEGREES PHARMACEUTICALS, INC. adjustments to additional paid in capital, fair value for the quarter ending 2023-06-30 was -$7.97K.
- 60 DEGREES PHARMACEUTICALS, INC. adjustments to additional paid in capital, fair value for the quarter ending 2023-03-31 was $5.13K.
- 60 DEGREES PHARMACEUTICALS, INC. adjustments to additional paid in capital, fair value for the quarter ending 2022-09-30 was $22.50K.
| Period end | Adjustments to Additional Paid in Capital, Fair Value 3 month | Adjustments to Additional Paid in Capital, Fair Value 6 month | Adjustments to Additional Paid in Capital, Fair Value 9 month |
|---|---|---|---|
| 2023-09-30 | $57.05K 10-Q · filed 2023-11-20 | $49.08K derived: sum of 2 quarters · filed 2023-11-20 | $54.22K derived: sum of 3 quarters · filed 2023-11-20 |
| 2023-06-30 | -$7.97K 10-Q · filed 2023-11-20 | -$2.83K derived: sum of 2 quarters · filed 2023-11-20 | |
| 2023-03-31 | $5.13K 10-Q · filed 2023-11-20 | ||
| 2022-09-30 | $22.50K 10-Q · filed 2023-11-20 | ||
| 2022-06-30 | $1.00K 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 |